Agemica
1 known investors
Find your way into Agemica
Agemica uses AI to rank disease mechanisms across omics data, targets, and safe-drug libraries, then tests predicted drug combinations in ex-vivo human cancer models to measure cancer-cell death, tumor-volume reduction, and healthy-cell safety. The company advances the strongest candidates toward humanized-mouse studies, IND-enabling work, and clinical development in the AI drug discovery and oncology space.
Founders & leadership
YK
Yasaman KalantarMotamediinCo-founder & Chief Technology Officer
Investors · 1
In the news
Frequently asked questions
- What does Agemica do?
- Agemica uses AI to rank disease mechanisms across omics data, targets, and safe-drug libraries, then tests predicted drug combinations in ex-vivo human cancer models to measure cancer-cell death, tumor-volume reduction, and healthy-cell safety. The company advances the strongest candidates toward humanized-mouse studies, IND-enabling work, and clinical development in the AI drug discovery and oncology space.
- Who founded Agemica?
- Agemica was founded by Yasaman KalantarMotamedi.
- Who are Agemica's investors?
- Agemica's investors include Valkyrie.